Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2020

Dec 3, 2020

59275_rns_2020-12-03_aa317599-4ce3-4ffc-84b9-8669bb496700.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

3[rd] December, 2020

  • (1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA

  • (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure of related party transactions for the half year ended 30[th] September, 2020

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 30[th] September, 2020.

This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.

This is for your information and record.

Thanking you,

Yours faithfully, For Cipla Limited

Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, RAJENDR 2.5.4.20=4987ad48c3965cfde78c8ea69e6f40ac91535876f12ba1fa5ba45cc5cc8db6cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd663669 f5314248a72fdcdf34d01d48d472d7cf9262 A CHOPRA 696f6, cn=RAJENDRA CHOPRA Date: 2020.12.03 15:36:47 +05'30' Rajendra Chopra Company Secretary

Prepared by: Pratiksha Mangaonkar

Consolidated disclosure of related party transactions and balances for the half year ended 30[th] September, 2020

Information on related party transactions as required by Ind AS-24 - 'Related Party Disclosures' are given below:

List of related parties

A. Associate

Stempeutics Research Private Limited Avenue Therapeutics, Inc. Brandmed (Pty) Limited AMPSolar Power Systems Private Limited GoApptiv Private Limited (w.e.f. 27[th] July, 2020)

B. Key management personnel

Ms. Samina Hamied - Executive Vice-Chairperson

Mr. Umang Vohra – Managing Director and Global Chief Executive Officer

Mr. Kedar Upadhye - Global Chief Financial Officer

C. Non executive chairman and non executive vice chairman

Dr. Y. K. Hamied, Chairman

Mr. M. K. Hamied, Vice Chairman

D. Non executive directors

Mr. Ashok Sinha

Mr. Adil Zainulbhai

Ms. Punita Lal

Ms. Naina Lal Kidwai

Dr. Peter Mugyenyi Mr. S. Radhakrishnan

E. Entities over which key management personnel are able to exercise significant influence

Cipla Foundation

Chest Research Foundation (Formerly known as Hamied Foundation upto 14[th] October, 2019) Cipla Cancer and AIDS Foundation

F. Trust over which entity has control/significant influence

Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund

==> picture [348 x 580] intentionally omitted <==

----- Start of picture text ----- ₹ in CroresFor the half year endedParticulars30 [th] September, 2020A. Remuneration (including sitting fees)Dr. Y.K. Hamied 1.01Mr. M.K. Hamied 1.03Ms. Samina Hamied 3.40Mr. Umang Vohra 8.12Mr. S. Radhakrishnan 1.06Mr. Kedar Upadhye 2.10Mr. Ashok Sinha 0.24Mr. Adil Zainulbhai 0.23Ms. Punita Lal 0.20Ms. Naina Lal Kidwai 0.22Dr. Peter Mugyenyi 0.4018.01 Expenses towards gratuity, compensated absences and premium paid for group health insurance hasnot been considered in above information as a separate actuarial valuation/premium paid are notavailable.B. Contribution to provident fund and other fundCipla Limited Employees Gratuity Fund 21.40Cipla Limited Employees Provident Fund 19.9641.36C. Donations givenCipla Foundation 10.7210.72D. Rent receivedDr. Y.K. Hamied (₹ 10,020/-) 0.000.00E. Purchase of AssetsStempeutics Research Private Limited 2.002.00F. Service Charges PaidStempeutics Research Private Limited 0.53GoApptiv Private Limited 5.886.41G. Reimbursement of operating/other expensesGoApptiv Private Limited 0.650.65H. Equity Investment made during the periodGoApptiv Private Limited 1.801.80I. Investment in Preference SharesGoApptiv Private Limited 4.004.00----- End of picture text -----

==> picture [348 x 354] intentionally omitted <==

----- Start of picture text ----- ₹ in CroresFor the half year endedParticulars30 [th] September, 2020J. Payable to key management personnel and non executive directorsDr. Y.K. Hamied 1.00Mr. M.K. Hamied 1.00Ms. Samina Hamied 1.15Mr. Umang Vohra 2.00Mr. S. Radhakrishnan 1.00Mr. Kedar Upadhye 0.51Mr. Ashok Sinha 0.20Mr. Adil Zainulbhai 0.18Ms. Punita Lal 0.18Ms. Naina Lal Kidwai 0.18Dr. Peter Mugyenyi 0.217.61K. Contribution payable to provident fundCipla Employees Provident Fund 10.3410.34L. Contribution payable to gratuity fundCipla Limited Employees Gratuity Fund 4.414.41M. Payable to AssociatesGoApptiv Private Limited 3.483.48N. Payable towards acquisition of stake in associateBrandmed (Pty) Limited 4.364.36----- End of picture text -----